
SNYR Stock Forecast & Price Target
SNYR Analyst Ratings
Bulls say
Synergy CHC is a diversified company with a range of consumer health care, beauty, and lifestyle products, including their flagship product FOCUSfactor and new venture into functional beverages. Despite a decrease in revenue for Q4 of 2025 due to stock shortages, the company has a strong market presence and has been given a BUY rating. While there are competition and risks, the potential for growth and success in their niche market make them a promising investment opportunity.
Bears say
Synergy CHC is operating well and is steadily expanding its product range, but due to the highly competitive nature of the consumer health and wellness industry, the company faces sales, growth, and profitability challenges. Additionally, the recent volatility in the stock price and dependence on international expansion could cause concern for investors. With a moderate discount rate and NPV analysis, we arrive at a BUY rating with a price target of $5.00.
This aggregate rating is based on analysts' research of Synergy CHC Corp and is not a guaranteed prediction by Public.com or investment advice.
SNYR Analyst Forecast & Price Prediction
Start investing in SNYR
Order type
Buy in
Order amount
Est. shares
0 shares